Ruifeng Guo

2.1k total citations
64 papers, 1.3k citations indexed

About

Ruifeng Guo is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ruifeng Guo has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Ruifeng Guo's work include Cutaneous Melanoma Detection and Management (11 papers), Cancer and Skin Lesions (8 papers) and Melanoma and MAPK Pathways (7 papers). Ruifeng Guo is often cited by papers focused on Cutaneous Melanoma Detection and Management (11 papers), Cancer and Skin Lesions (8 papers) and Melanoma and MAPK Pathways (7 papers). Ruifeng Guo collaborates with scholars based in United States, China and France. Ruifeng Guo's co-authors include D. Gale Johnson, David L. Mitchell, Jie Chen, P. R. Henry, R.D. MILES, Ramon C. Littell, C. B. Ammerman, Robert A. Holwerda, Jianwen Cao and Andrew R. Tee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ruifeng Guo

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruifeng Guo United States 14 641 301 217 173 155 64 1.3k
Elke Ueberham Germany 22 573 0.9× 144 0.5× 64 0.3× 85 0.5× 61 0.4× 33 1.4k
Young‐Han Song South Korea 16 877 1.4× 262 0.9× 66 0.3× 41 0.2× 91 0.6× 48 1.3k
A. Zimber Israel 18 701 1.1× 461 1.5× 106 0.5× 52 0.3× 73 0.5× 52 1.4k
Darryl L. Hadsell United States 29 1.2k 1.8× 581 1.9× 98 0.5× 408 2.4× 30 0.2× 59 2.5k
Shuji Ueda Japan 21 807 1.3× 126 0.4× 167 0.8× 42 0.2× 27 0.2× 61 1.3k
Xianzhi Jiang United States 18 583 0.9× 141 0.5× 35 0.2× 62 0.4× 67 0.4× 25 1.1k
Chie Suzuki Japan 14 540 0.8× 138 0.5× 45 0.2× 40 0.2× 92 0.6× 26 898
Sabine Novak Austria 12 1.1k 1.7× 222 0.7× 36 0.2× 77 0.4× 126 0.8× 14 2.0k
Jiantao Cui China 19 601 0.9× 194 0.6× 147 0.7× 54 0.3× 34 0.2× 35 995

Countries citing papers authored by Ruifeng Guo

Since Specialization
Citations

This map shows the geographic impact of Ruifeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Guo more than expected).

Fields of papers citing papers by Ruifeng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruifeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Guo. The network helps show where Ruifeng Guo may publish in the future.

Co-authorship network of co-authors of Ruifeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ruifeng Guo. A scholar is included among the top collaborators of Ruifeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifeng Guo. Ruifeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Ruifeng, et al.. (2025). Utility of Immunohistochemistry in Diagnosis of Papillary Eccrine Adenoma/Tubular Apocrine Adenoma (PEA/TAA). American Journal of Dermatopathology. 47(10). 808–809.
2.
Guo, Ruifeng, et al.. (2025). Every day a new fusion? – An update on recent discoveries in dermatopathology. Human Pathology. 169. 106011–106011.
3.
Guo, Ruifeng, et al.. (2025). First insight into eosinophils as a biomarker for the early distinction of COVID-19 from influenza A in outpatients. Experimental and Therapeutic Medicine. 29(3). 56–56.
4.
Zhou, Xiaolei, Xingyue Wang, & Ruifeng Guo. (2025). Assessment model of ozone pollution based on SHAP-IPSO-CNN and its application. Scientific Reports. 15(1). 3404–3404. 2 indexed citations
5.
Dehner, Carina, Daniel Pissaloux, Franck Tirode, et al.. (2025). ACTB::ZMIZ2-rearranged adnexal carcinoma: a second case. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 871–875. 1 indexed citations
6.
Nguyen, Amanda J., et al.. (2024). Uncovering the hidden risk of metastatic cutaneous basal cell carcinoma by molecular profiling: A retrospective review. JAAD International. 16. 189–191. 1 indexed citations
7.
Dehner, Carina, Emma F. Johnson, Michael Camilleri, et al.. (2024). Fusion‐driven cutaneous and superficial mesenchymal and adnexal tumors—A clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2‐rearranged adnexal carcinoma. Journal of Cutaneous Pathology. 51(7). 538–548. 4 indexed citations
8.
9.
Buglioni, Alessia, Ruifeng Guo, Kandelaria M. Rumilla, et al.. (2023). An Unexpected Diagnosis Uncovered by Quantitative Molecular Findings: A Case Report. Journal of the National Comprehensive Cancer Network. 21(8). 787–791. 1 indexed citations
10.
Bois, Melanie C., et al.. (2023). Calciphylaxis in autopsy: A retrospective case-controlled study of 7 decedents. JAAD Case Reports. 35. 60–62.
11.
Leontovich, Alexey A., Raymond M. Moore, Wendy K. Nevala, et al.. (2022). Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade. Cancer Research Communications. 2(2). 78–89. 6 indexed citations
12.
LeBlanc, Robert E., Shaofeng Yan, Aravindhan Sriharan, et al.. (2022). Molecular analysis of NUT‐positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions. Journal of Cutaneous Pathology. 49(10). 850–858. 13 indexed citations
13.
Guo, Ruifeng, et al.. (2022). Sinonasal Mucosal Melanoma: Role of Tumor Proliferative Indices and Pathological Factors in Survival. The Laryngoscope. 132(12). 2350–2358. 11 indexed citations
14.
Geiersbach, Katherine B., Troy J. Gliem, Athanasios Gaitatzes, et al.. (2022). Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic Tumors. Journal of Molecular Diagnostics. 24(11). 1160–1170. 4 indexed citations
15.
Guo, Ruifeng, et al.. (2020). Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma—A Single Institutional Experience and Literature Review. American Journal of Dermatopathology. 43(1). 9–14. 5 indexed citations
16.
Nguyen, Ba D. & Ruifeng Guo. (2020). Multimodality imaging of multiple duodenal gangliocytic paragangliomas with post-surgical recurrence. Digestive and Liver Disease. 53(1). 122–124. 1 indexed citations
17.
Guo, Ruifeng & Andrew L. Folpe. (2015). Extensively Myxoid and Hyalinized Sinonasal Capillary Hemangiomas. The American Journal of Surgical Pathology. 39(11). 1584–1590. 1 indexed citations
18.
Chen, Jie, Feng Zhu, Anup Biswas, et al.. (2011). E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle. 10(8). 1287–1294. 59 indexed citations
19.
Chen, Jian, et al.. (2010). [Expression of androgen receptor in breast carcinoma and its relationship with estrogen receptor, progesterone receptor and HER2 status].. PubMed. 39(11). 743–6. 5 indexed citations
20.
Cao, Jianwen, P. R. Henry, Ruifeng Guo, et al.. (2000). Chemical characteristics and relative bioavailability of supplemental organic zinc sources for poultry and ruminants.. Journal of Animal Science. 78(8). 2039–2039. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elke Ueberham Breakdown of academic impact, for papers by Young‐Han Song Breakdown of academic impact, for papers by A. Zimber Breakdown of academic impact, for papers by Darryl L. Hadsell Breakdown of academic impact, for papers by Shuji Ueda Breakdown of academic impact, for papers by Xianzhi Jiang Breakdown of academic impact, for papers by Chie Suzuki Breakdown of academic impact, for papers by Sabine Novak Breakdown of academic impact, for papers by Jiantao Cui
Rankless by CCL
2026